Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s DrugAuthorPosted byPublishedJune 10, 20249:34 pmX (Twitter)FacebookLinkedInShare this postShare this postClose sharing boxAdvisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s DrugX (Twitter)FacebookLinkedInPosted by on June 10, 2024. The modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously. Post Views: 17